CPMI - Clinical Pharmacology of Miami - Part of the ERG Network
An ERG portfolio Company

Volunteers Call:

Conditions We Research


As a dynamic independently held clinical research site company, The ERG research areas offers a deep bench of specialized expertise in more than 50 specific indications, with unparalleled capabilities in CNS studies.


Phase I studies help researchers determine how a drug works, by understanding its clinical pharmacology. Having conducted over 2000 Phase I studies, ERG is known throughout the industry for excelling in these trials. Most Phase I studies are conducted in normal healthy volunteers (NHV); NHVs are also used as a cohort of a Phase I study in metabolic, neurologic, psychiatric, endocrine, and cardiac disorders. We have access to a wide range of healthy subject profiles, and, whatever your compound, we stand ready to help you explore its clinical pharmacology.

Demonstrated Expertise in Key Indications

  • Human Abuse Liability
  • Respiratory Depression
  • ETOH interaction
  • First-in-Human
  • Cardiac Safety, Thorough QT/QTc
  • Absolute Bioavailability
  • Bioequivalence
  • Drug-Drug Interaction
  • First-to-File
  • Food Effect
  • Patch Irritability
  • Pharmacokinetic/Pharmacodynamic
  • Relative Bioavailability

Learn more on ERGClinical.com +